bevacizumab,olaparib
Roche,Merck,Astrazeneca
['bevacizumab', 'olaparib', ' bev ', 'brca', 'confirm,(-confirma),(-confirme)', 'ovarian', 'paola-1']
keep up with the latest from #esmo22 with #noeticinsight! os findings from the paola-1/engot-ov25 phase iii trial confirm olaparib + bevacizumab after 1l pbc + bev is soc in adv ovarian cancer + homologous recombination deficiency, with or w/o tumor brca1/2 mutation 